China Universal Asset Management Co., Ltd. Intellia Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 18,474 shares of NTLA stock, worth $423,978. This represents 0.07% of its overall portfolio holdings.
Number of Shares
18,474
Previous 18,474
-0.0%
Holding current value
$423,978
Previous $508,000
-0.0%
% of portfolio
0.07%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$252 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$209 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$209 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$106 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$96.6 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.74B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...